Intas Pharmaceuticals Valid
CEP Certificates (EDQM COS List)
Intas Pharmaceuticals Valid
CEP Database
Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.
- Total Records 21
- Latest End Date -
- Data Source EDQM
- Last Updated 2026-04-24
Company Overview
Company
Intas Pharmaceuticals Valid
Country
India
Website
Social Profiles
Company Snapshot
Intas Pharmaceuticals Valid
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad, Gujarat
India
intaspharma.com/ generalqueries@intaspharma.com View on MapCEP Records Timeline (21 records)
Product
Capecitabine, Process-III
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2025-176 - Rev 01
Substance No.
2762
Issue Date
2026-04-24
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2025-176 - Rev 01
Substance No.: 2762
Product
Doxorubicin Hydrochloride
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2012-367 - Rev 03
Substance No.
714
Issue Date
2026-03-11
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-367 - Rev 03
Substance No.: 714
Product
Pregabalin, Process II, Milled, Form-I
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2022-028 - Rev 03
Substance No.
2777
Issue Date
2026-03-04
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-028 - Rev 03
Substance No.: 2777
Product
Gemcitabine hydrochloride, Process III
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2022-092 - Rev 03
Substance No.
2306
Issue Date
2026-02-23
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-092 - Rev 03
Substance No.: 2306
Product
Trazodone hydrochloride, Process-II, Milled/Unmilled
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2025-141 - Rev 02
Substance No.
2857
Issue Date
2026-02-19
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2025-141 - Rev 02
Substance No.: 2857
Product
Capecitabine, Process II
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2019-143 - Rev 02
Substance No.
2762
Issue Date
2025-11-24
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2019-143 - Rev 02
Substance No.: 2762
Product
Docetaxel, Process-IIb
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2020-155 - Rev 02
Substance No.
2593
Issue Date
2025-07-25
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2020-155 - Rev 02
Substance No.: 2593
Product
Trazodone hydrochloride, Milled, Unmilled
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2024-228 - Rev 00
Substance No.
2857
Issue Date
2025-04-07
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2024-228 - Rev 00
Substance No.: 2857
Product
Fingolimod hydrochloride
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2020-090 - Rev 02
Substance No.
2988
Issue Date
2025-03-14
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2020-090 - Rev 02
Substance No.: 2988
Product
Ticagrelor, Form II, micronised
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2022-333 - Rev 01
Substance No.
3087
Issue Date
2025-01-22
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-333 - Rev 01
Substance No.: 3087
Product
Imatinib mesilate, β-form
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2018-047 - Rev 03
Substance No.
2736
Issue Date
2025-01-21
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-047 - Rev 03
Substance No.: 2736
Product
Lacosamide, Form I, milled
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2018-247 - Rev 02
Substance No.
2992
Issue Date
2024-11-28
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-247 - Rev 02
Substance No.: 2992
Product
Rivaroxaban, Form-I, micronised
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2020-178 - Rev 01
Substance No.
2932
Issue Date
2024-11-15
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2020-178 - Rev 01
Substance No.: 2932
Product
Teriflunomide
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2021-384 - Rev 02
Substance No.
3036
Issue Date
2024-11-06
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-384 - Rev 02
Substance No.: 3036
Product
Carmustine
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
CEP 2019-272 - Rev 02
Substance No.
1187
Issue Date
2024-10-14
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2019-272 - Rev 02
Substance No.: 1187
Product
Pregabalin
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
R1-CEP 2017-149 - Rev 00
Substance No.
2777
Issue Date
2023-07-07
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2017-149 - Rev 00
Substance No.: 2777
Product
Paclitaxel, Produced by semi-synthetic process
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
R1-CEP 2012-385 - Rev 01
Substance No.
1794
Issue Date
2022-07-19
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2012-385 - Rev 01
Substance No.: 1794
Product
Gemcitabine hydrochloride
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
R1-CEP 2009-089 - Rev 02
Substance No.
2306
Issue Date
2022-07-13
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2009-089 - Rev 02
Substance No.: 2306
Product
Docetaxel, Process-II
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
R1-CEP 2015-047 - Rev 01
Substance No.
2593
Issue Date
2022-07-13
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2015-047 - Rev 01
Substance No.: 2593
Product
Capecitabine
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
R1-CEP 2015-325 - Rev 01
Substance No.
2762
Issue Date
2022-06-24
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2015-325 - Rev 01
Substance No.: 2762
Product
Paclitaxel, Produced by a semi-synthetic process – Process II
Substance
INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
Certificate No.
R0-CEP 2021-455 - Rev 00
Substance No.
1794
Issue Date
2022-04-08
End Date
-
Country
India
Identifiers
Certificate No.: R0-CEP 2021-455 - Rev 00
Substance No.: 1794
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
22 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
Status Breakdown
21 total- Valid
Official Source
All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).
Visit EDQMRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Country
India
Identifiers
Certificate No.: CEP 2025-176 - Rev 01
Substance No.: 2762
100% Official Data
Directly from the EDQM CEP database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.